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Abstract 
Recent studies have shown that cellular bioenergetics may be involved in stem cell 
differentiation. Considering that during cancerogenesis cells acquire numerous properties of 
stem cells or dedifferentiate, it is possible to assume that the energy metabolism in 
tumorigenic cells might be differently regulated. The aim of this study was to compare the 
mitochondrial bioenergetic profile of normal pluripotent human embryonic stem cells (hESC) 
and relatively nullipotent embryonal carcinoma cells (2102Ep cell line). 
We examined three parameters related to cellular bioenergetics: phosphotransfer system, 
aerobic glycolysis, and oxygen consumption. Activities and expression levels of main 
enzymes that facilitate energy transfer were measured. The oxygen consumption rate studies 
were performed to investigate the respiratory capacity of cells. In addition, we applied 
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metabolic control analysis to identify target reactions that control oxygen consumption in both 
cell lines. 
2102Ep cells showed a shift in energy distribution towards adenylate kinase network. The 
total AK activity was almost 3 times higher in 2102Ep cells compared to hESCs (179.85±5.73 
vs 64.39±2.55 mU/mg of protein) and the expression of AK2 was significantly higher in these 
cells, while CK was downregulated. 2102Ep cells displayed reduced levels of oxygen 
consumption and increased levels of aerobic glycolysis compared to hESCs. The 
compromised respiration of 2102Ep cells is not the result of increased mitochondrial mass, 
increased proton leak, and reduced respiratory reserve capacity of the cells or impairment of 
respiratory chain complexes. We also noted that the respiration chain might be distinctly 
organized in studied cell lines since FCC values for complexes II and IV, ATP synthase and 
ANT were considerably higher in 2102Ep cells than in hESCs that value in hESCs. 
Our data showed that the bioenergetic profile of 2102Ep cells clearly distinguishes them from 
normal hESCs. This should be considered when this cell line is used as a reference, and 
highlight the importance of further research concerning energy metabolism of stem cells. 
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Highlights: 
• bioenergetic profile of 2102Ep embryonal carcinoma cells clearly distinguishes them 
from normal hESCs 
• 2102Ep cells have elevated levels of adenylate kinase 2 and reduced levels of creatine 
kinase compared with hESCs 
• 2102Ep cells display reduced levels of OXPHOS and elevated levels of aerobic 
glycolysis 
• respiration chain is distinctly regulated in 2102Ep cells compared with normal hESCs 
 
1 Introduction	
There are increasing evidences that cancer could be considered as a stem cell disease [1]. As 
aging induces mutations in stem cells [1], it supports the idea of cancer stem cells (CSCs) 
evolving from different stem cell compartments. CSC has been defined as “a cell within a 
tumor that possesses the capacity to self-renew and to cause the heterogeneous lineages of 
cancer cells that comprise the tumor”[2]. It has been demonstrated that CSCs are involved in 
cancer onset and development, distant metastasis, angiogenesis and drug resistance [3]. The 
development of specific strategies to eradicate highly malignant CSCs holds a great potential 
for cancer treatment [4-5]. In light of novel observations on how core metabolic properties of 
CSCs might contribute to tumor progression and resistance to conventional treatment, the 
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cellular metabolism of CSCs may represent an attractive target for cancer therapy. However, 
these therapies may cause toxicity to normal stem cells, which share many common features 
with CSCs [6]. In order to develop safe and effective cancer therapy, it is crucial to 
understand shared and distinguishing mechanisms that regulate proliferation in normal and 
cancer stem cells. 
The bioenergetic profiles of various human progenitor and stem cells are just being 
understood. It is clear now, that energy metabolism plays an important role in the homeostasis 
and differentiation of stem cells. Differentiation of the cell is accompanied by changes in 
mitochondrial metabolism, activity and organization of electron transport chain (ETC) 
complexes [7-9]. Moreover, recent studies have demonstrated that mitochondrial metabolism 
itself can influence the stemness maintenance and differentiation process [9-10]. Although 
stem cells contain fewer number and morphologically more immature mitochondria than 
differentiated cells[9], the ETC complexes within the inner membrane of the mitochondria are 
functionally active and mitochondria are able to consume oxygen and produce ATP from 
oxidative phosphorylation (OXPHOS)[10-11]. 
The reprogramming of energy metabolism is proposed as one of the hallmarks of cancer[12]. 
It has been shown that cancer cells are able to modulate their energy metabolism via aerobic 
glycolysis[13]. This inclination of cancer cells to use glycolysis even in the presence of 
oxygen characterizes also normal stem cells[14]. One of the mechanisms that explain high 
glycolytic rate in tumor cells at normoxic condition is Warburg-Pedersen model[15]where the 
association between glycolytic enzyme hexokinase (HK) and mitochondrial outer membrane 
enhances aerobic glycolysis in cancer cells. It has been demonstrated that HK bound to 
voltage dependent anion channel (VDAC) utilizes ATP produced during OXPHOS to catalyze 
the first reaction of glycolysis[15]. A similar mechanism may occur in stem cells, which also 
overexpress HK enzymes[10]. 
Well-organized high-energy phosphoryl transfer system is required to mediate intracellular 
communication between ATP-consuming and ATP-producing cellular compartments and thus 
maintain normal growth and development of cell [16].The main components of 
phosphotransfer system are adenylate kinase (AK) network, creatine kinase (CK) network and 
glycolysis[16]. CK network maintains normal phosphate levels in cells with high energy 
demands. Mitochondrial CK isoforms, CKMT1A and CKMT2, as well as cytosolic isoform, 
CKB, provide energy for various cellular processes[16]. AK1, the major cytosolic isoform, 
and AK2, localized in mitochondrial intermembrane space, have been recognized as the main 
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facilitators of intracellular nucleotide exchange in cells with compromised CK network. AK4, 
enzymatically inactive isoform, has been proposed as a marker of poor clinical outcome for 
lung cancer [17]. 
Recent studies have shown that adenylate kinase and creatine kinase networks are involved in 
the differentiation of hematopoietic stem cells facilitating energy transfer and metabolic 
signaling required for developmental programming [18-19]. The cancerogenesis has been also 
associated with the reorganization of the phosphotransfer system. The creatine kinase system 
is significantly downregulated in various cancer types including breast cancer [20], Ehrlich 
ascites carcinoma [21], neuroblastoma[22], colorectal cancer [23] and prostate cancer [24]. 
On the contrary, AK levels were found to be elevated in several types of cancer [22-23]. 
However, the exact role of CK and AK enzymes in the regulation of cell stemness or cancer 
development remains elusive. 
In the present study, we used 2102Ep cell line derived from a primary human testicular 
teratocarcinoma [25] as a CSC model. Described as relatively nullipotent,.this cell line has 
been shown to express many of the identified markers of pluripotent hESCs[26], as well as, 
numerous oncogenes and has many potentially tumorigenic genomic alterations [27]. 
Embryonic stem cell-like gene expression signature has been found to be characteristic of 
poorly differentiated aggressive tumors [28-29]. With limited differentiation potential 2102Ep 
resembles these undifferentiated cancer cells that are often associated with poor prognosis of 
cancer patients. Embryonic stem cells represent the normal counterparts of embryonal 
carcinoma cells and together, these can be used as complementary tools for studying 
pluripotency, stem cell biology and cancer[30].We examined differences between normal 
human embryonic stem cells and 2102Ep cells in the three parameters related to cellular 
bioenergetics: phosphotransfer system, aerobic glycolysis, and oxygen consumption. In 
addition, we applied the metabolic control analysis to compare the effect of inhibition of 
different respiratory complexes on the respiratory efficiency in the two cell lines. 
 
2 Material	and	methods	
2.1 Cell	cultures	
2.1.1 2102Ep	cell	line	
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The human embryonal carcinoma cell line 2102Ep(Cl.2/A6; GlobalStem)was routinely 
cultured in T75 (Greiner bio-one) flasks in high glucose Dulbecco’s modified Eagle medium 
with L-glutamine, supplemented with 10% heat inactivated fetal bovine serum (FBS), 
penicillin (100 U/ml), streptomycin (100 µg/ml) and 50 µg/ml gentamicin. Cells were grown 
at high density to limit spontaneous differentiation[31]and maintained at 37°C in a humidified 
incubator containing 5% CO2 in the air. 
2.1.2 H9	cell	line	
Pluripotent H9 human embryonic stem cells (WA09, National Stem Cell Bank, WiCell) were 
cultured on 6-well tissue culture plates (BD Biosciences) coated with Matrigel (BD 
Biosciences) in mTeSR1 media (STEMCELL Technologies) according to the manufacturer’s 
specifications.The culture medium was changed daily. Cells were passaged mechanically with 
micropipette tip after 3-4 days and cultured in the presence of 5% CO2 at 37°C in humid 
conditions. Normal karyotype of the cells was confirmed by G-banding. 
2.1.3 Oxygen	consumption	rate	(OCR)	study	
The rates of oxygen consumption were measured at 25°C using an Oxygraph-2k (Oroboros 
Instruments, Innsbruck, Austria).Measurements were performed in Mitomedium B solution 
supplemented with 5mM glutamate, 2mM malate and 1mg/ml BSA. A suspension of cells (1x 
106 cells/ml) was placed in the oxygraph chamber, permeabilized with saponin (40µg/ml) and 
allowed to equilibrate for 5 min.10mM succinate was added to initiate electron transport 
through Complex II. State 2 respiration was monitored and after that 2 mM ADP was added to 
evaluate state 3 respiration. Respiration rates were normalized to the total protein amount in 
the cells and expressed as nmol of O2 consumed per /min/per mg of total protein (nmol/(min x 
mg). Protein concentrations were determined using the Pierce BCA Protein Assay Kit. 
The functional coupling between HK and mitochondria was measured as described earlier. 
[23, 32]. The functional activities of respiratory chain complexes were studied by substrate-
inhibitor titration [23, 33]. 
Mitochondrial contribution to the energy metabolism was measured in non-permeabilized 
cells. Following stabilization of endogenous routine respiration (ROUTINE) 2 µg/ml of 
oligomycin was added to inhibit ATP synthesis and induce the nonphosphorylating leak state 
(LEAK). Maximal uncoupled respiratory rates were determined with FCCP titration followed 
by inhibition of electron transfer by 10 µM antimycin A to measure residual oxygen 
consumption (ROX). 
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2.1.4 Metabolic	control	analysis	(MCA)	
In MCA, the degree of the control that a given enzyme exerts on the flux can be described 
quantitatively as a flux control coefficient (FCC). If the enzyme exerts an elevated control 
over the regulation of the metabolic pathway, then even a small change in the given enzyme 
activity will promote a significant variation in the pathway flux[34-35]. 
FCCs were determined for all mitochondrial ETC complexes, adenine nucleotide translocator 
(ANT) and inorganic phosphate carrier after their stepwise titration with specific pseudo 
irreversible inhibitors upon direct activation of respiration by exogenously added ADP (at 2 
mM). The following inhibitors were used: rotenone for Complex-I of the mitochondrial 
electron transport chain (ETC); atpenin A5for Complex-II; antimycin A for Complex-III; 
sodium cyanide for Complex-IV; oligomycin for complex-V (ATP synthase); 
carboxyatractyloside (CAT) for ANT; and mersalyl for inorganic phosphate carrier. 
2.1.5 Assays	of	enzymes	activity	
The enzyme activities were studied spectrophotometrically at 25 °C using a Cary 100 Bio 
UV-visible spectrophotometer. The activity of HK was measured as the total glucose 
phosphorylating capacity of whole cell extracts, using a standard glucose-6-phosphate 
dehydrogenase (G6PDH)-coupled spectrophotometric assay [36].The activity of CK was 
measured by a coupled enzyme assay in the presence of di(adenosine-5′) pentaphosphate 
(adenylate kinase inhibitor[37]), 20 mM phosphocreatine (PCr) and with 2 U/ml G6PDH and 
2 U/ml HK as the coupled enzymes[38]. 
The total AK activity was also measured by a coupled enzyme assay[39]. In order to 
determine the specific activities of AK1 and AK2, lysates were incubated with AK1 inhibitor 
N-ethylmaleimide(NEM) for 1h at 25°C.AK2 activity was determined as the activity 
remaining after the NEM treatment. AKl activity was calculated as total AK activity minus 
activity remaining after the NEM treatment. 
The activity of citrate synthase (CS) was measured by monitoring the production of CoA from 
oxaloacetate together with acetyl-CoA. The thiol group of CoA reacts with 5,5’-dithiobis-(2-
nitrobenzoic acid) (Ellman’s reagent, DTNB) to produce a yellow-colored product which was 
observed by measuring the absorbance at 412 nm. Reactions were performed in 96-well plates 
containing 100mMTris-HCl pH 8.1, 0.3mMAcCoA, 0.5mM oxaloacetate and 0.1mM DTNB 
using FLUOstar Omega plate-reader spectrophotometer (BMG Labtech). 
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2.1.6 Confocal	imaging	
2102Ep cells were seeded on glass coverslips in 12-well plates (Greiner bio-one) and allowed 
to adhere overnight. H9 cells were passaged onto Matrigel coated glass coverslips and 
cultured in 12-well plates for 3 days. Then, the growth mediumwas removed and cells were 
incubated with 200nMMitoTracker Red CMXRos for 30 min at 37°C to stain mitochondria. 
After staining, cells were fixed in 4% paraformaldehyde in PBS during 15 min at RT. 
Following permeabilization with ice-cold methanol for 20min at RT,cells were incubated with 
2% BSA in PBS for 1 h at RT, probed with specific primary antibodies against Oct-4 and 
incubated for 1h at RT. After incubation, cells were washed with PBS and incubated with 
corresponding fluorescence-conjugated secondary antibodies. Finally, cells were incubated 
for 15 min at RT with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI, Molecular 
Probes™) to visualize the cell nucleus. Cells were imaged by an Olympus FluoView FV1000 
inverted laser scanning confocal microscope. 
2.1.7 Isolation	of	RNA,	cDNA	synthesis	and	qPCR	
Total RNA from Ep2102 and hES cells was isolated using FavorPrep™ Blood/Cultured Cell. 
Total RNA Mini Kit (Favorgen Biotech Corporation) and quantitated using a Nanodrop 
spectrophotometer (ND-1000; Nanodrop). Following DNaseI (Thermo Fisher Scientific) 
treatment, reverse transcription was performed on 1 µg of total RNA with random hexamer 
primers using RevertAid RT Reverse Transcription Kit (Thermo Fisher Scientific) according 
to the manufacturer protocol. The synthesized cDNA was subjected to quantitative PCR 
analysis using 5x HOT FIREPol® Probe Universal qPCR Mix (Solis BioDyne) and specific 
primers actin beta – Hs01060665_g1; hexokinase I – Hs00175976_m1; hexokinase II – 
Hs00606086_m1; creatine kinase brain-type HS00176484_m1; creatine kinase, mitochondrial 
1B – Hs00179727_m1; creatine kinase, mitochondrial 2 – Hs00176502_m1, adenylate kinase 
1 HS00176119_m1; adenylate kinase 2 HS01123132_g1; adenylate kinase 4 
HS03405743_g1. All qPCR experiments were performed on LightCycler 480 II Real-Time 
PCR System (Roche) with following conditions: 95 °C for 10 min followed by 40 cycles of 
95 °C for 15 sec and 60 °C for 1 min. PCR reactions were performed in triplicate for each of 
three independent experiments and included no reverse transcriptase and no template negative 
controls. Threshold cycles (Ct) were automatically calculated by LightCycler 480 software 
(Roche). Data were analyzed with the formula 2–ΔΔCt (Livak and Schmittgen, 2001), 
normalized to the endogenous control ActB and expressed as fold change over hESC samples. 
2.1.8 Statistical	analysis	of	data	
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All data points are presented as means ± standard error (SEM) from at least five separate 
experiments performed in duplicate. Significance was calculated by Student’s t-test; 
differences between two data groups were considered to be statistically significant when p< 
0.05. 
3 Results	
3.1 2102Ep	cells	displayedelevated	levels	of	adenylate	kinase	2	(AK2)	and	
reduced	levels	of	creatine	kinase	(CK)	compared	to	hESCs	
2102Ep demonstrated a distinct expression pattern of key enzymes that are involved in 
cellular energy homeostasis (Fig.1). The measurements of enzymatical activities further 
clarified the differences between hESC and 2102Ep cells. Compared to hESCs, the total 
creatine kinase activity was significantly decreased in 2102Ep cells (Table1) in accordance 
with the down-regulation of creatine kinase mitochondrial (CKMT1A) and brain (CKB) 
isoforms (Fig.1). Interestingly, both cell lines had very low expression of CKMT2 and the 
expression level of CKMT1A was significantly higher. This suggests CKMT1A to be the 
main isoform of mitochondrial CK expressed in these cells. Concomitantly, the total 
adenylate kinase activity was significantly increased in 2102Ep cells (Table 1)  and was most 
probably associated with a nearly 2-foldhigher expression level of AK2 isoform in 2102Ep 
cells than in hESC (Fig.1). Although the expression of AK1 was lower in 2102Ep cells 
(Fig.1), this was not reflected on its enzymatical activity (Table 1). We observed no statistical 
difference in the expression levels of AK4 between two cell lines (Fig.1). 
3.2 The	respiration	is	compromised	in	2102Ep	cells	compared	to	hESCs	
To characterize the ability of cells to consume oxygen we performed OCR studies. The 
intactness of mitochondrial outer and inner membranes was controlled by standard 
mitochondrial membrane integrity test (Fig.2A)[40]. The addition of cytochrome c (8 µM) 
had no effect on oxygen consumption rate, while the addition of carboxyatractyloside (1 µM) 
decreased the respiration rate to the basal level indicating the intactness of outer and inner 
mitochondrial membranes. In order to ensure the quality of the cells, this test was performed 
prior to every experiment. 
State 2 (in the absence of ADP) and state 3 (in the presence of ADP) respiration rates were 
determined and compared between these two cell lines. State 3 respiration rate in 2102Ep 
cells was remarkably lower than in hESCs (5.04±0.37 versus 7.45±0.58, 
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p=0.01)(Fig.2B).Respiratory control ratios (RCRs) were calculated as the ratios between state 
2 and state 3 respiration. Because of reduced state 3 respiration, RCR was two times lower in 
the 2102Ep cells (1.98±0.10 versus 3.99±0.36,p=0.005) (Fig.2C). 
3.3 Mitochondrial	contribution	to	the	energy	metabolism	of	hESCs	and	
2102Ep	cells	
For the understanding of mitochondrial contribution to the energy metabolism of hESC and 
2102Ep cell lines, we analyzed OCR response of these cells to the combination of inhibitors 
(oligomycin, antimycin) and uncoupler of OXPHOS (FCCP) (Fig.3A, B). After monitoring 
routine respiration, oligomycin, the inhibitor of ATP synthase, was added to uncouple the 
ATP-linked respiration from the proton leak. As shown in figure 3C, 50% of routine 
respiration (State 2 respiration measured without permeabilization of the cell membrane) was 
dedicated to ATP production. The proton leak appears to be very similar in these two cell 
lines, accounting approximately 25% of the cellular respiration rate, indicating that the 
suppressed respiration of 2102Ep cells is not due to the decreased proton leak. After addition 
of oligomycin, maximal respiratory rate was determined by FCCP treatment. FCCP is a 
protonophore that uncouples electron transport and mitochondrial respiration from ATP 
synthesis by dissipating the proton gradient. The addition of FCCP resulted in an increase of 
oxygen consumption levels in both cell lines with a more pronounced response in 2102Ep 
cells. The difference between oxygen consumption rate following FCCP treatment and State 2 
respiration rate represents the respiratory capacity of these cells. We observed that the 
mitochondrial respiratory capacity was higher for 2102Ep cells when compared with hESCs 
(Fig.3C).The addition of mitochondrial Complex I and III inhibitors rotenone and antimycin 
reduced respiration rates in both cell lines, although this effect was significantly more 
pronounced in 2102Ep cells (Fig.3B). 
3.4 2102Ep	demonstrated	stronger	coupling	between	HK	and	OXPHOS	
than	hESCs	
To examine if reduced level of oxygen consumption is associated with increased level of 
glycolysis in 2102Ep cells, we compared the activity and expression levels of HK, an enzyme 
that catalyzes the first reaction of glycolysis, between these two cell lines. Although 2102Ep 
cells had a 2-fold decrease in HK2 mRNA level, the total HK activity was similar between 
studied cell lines (Fig.1, Table 1). 
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To evaluate the coupling between HK and OXPHOS, we investigated the effect of glucose on 
cellular respiration (Fig.4). It can be seen that addition of 0.1 mM ATP increased in the 
respiration rate  due to the generation of a large flux of ADP from ATPases in hESCs. The 
effect of glucose on the oxygen consumption was characterized by glucose index (Iglu), which 
represents the degree of glucose-stimulated respiration compared to maximal ADP-stimulated 
respiration. The Iglu calculated for 2102Ep cells was considerably higher compared to hESCs, 
55.16±2.21 versus 40.18±4.64, respectively (p=0.06), suggesting that coupling between HK 
reactions and OXPHOS are more pronounced in2102Ep cells (Fig.4B). These results suggest 
that 2102Ep cells prefer more aerobic glycolysis to produce ATP than hESC. 
3.5 hESCs	and	2102Ep	have	a	functional	mitochondrial	respiratory	chain	
In order to identify mechanisms of mitochondrial respiratory chain that could account for the 
lower oxygen consumption rate in 2102Ep, we examined the functional activity of respiratory 
chain complexes I-IV and ATP-synthase in both cell types. Our data demonstrated that all 
complexes within the mitochondrial respiratory chain of hESCs and 2102Ep cells were 
functionally active and their activities were equivalent in both cell lines (Fig.5). Firstly, ADP 
stimulated respiration was blocked by rotenone (20 µM, Complex I inhibitor), restored by 
addition of succinate (10 mM, Complex II substrate) and then, inhibited again by antimycin A 
(10 µM, Complex III inhibitor), indicating the functional activity of Complexes I, II and III. 
Finally, the functional activity of Complex IV was confirmed by the addition of electron 
donors ascorbic acid (5mM) and N,N,N’,N’-tetramethyl-p-phenylenediamine(TMPD, 1 
mM),which strongly enhanced oxygen consumptionin both cell types (Fig.5). 
The morphological features of hESC and 2102Ep cells were examined by confocal 
microscopy (Fig.6). Although both cell lines expressed pluripotency marker Oct-4 and 
contained some spontaneously differentiated cells, there were several differences in cell 
morphology. While hESCs grow as colonies and display high nucleus to cytoplasm ratio, 
2102Ep cells grow as a monolayer and contain considerably larger volumes of cytoplasm. 
Consistent with previous reports[9], hESCs display punctuate mitochondria with 
predominantly perinuclear localization, whereas in 2102Ep cells mitochondria localize 
randomly in the cytoplasm (Fig.6). To ensure that alterations in mitochondrial respiration 
rates were not due to differences in mitochondrial content, the CS activity assay was 
performed. Our results (Table 1) indicated a similar mitochondrial mass in both cell lines. 
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3.6 Metabolic	control	analysis	revealed	the	differences	of	regulation	of	
cellular	respiration	in	2102Ep	and	hESCs	
To further analyze mitochondrial respiration in hESCs and 2102Ep cells, the sensitivity of 
mitochondrial respiratory chain complexes to specific inhibitors was measured and the degree 
of control that each individual complex exerts on whole respiration chain was evaluated using 
MCA method[41]. Flux control coefficients (FCC) for mitochondrial complexes I-IV, ATP-
synthase, adenine nucleotide translocator (ANT) and phosphor carrier (Pi) are summarized in 
Table 2. Our results showed that the key sites for the regulation of respiration are Complex I 
(FCC=0.76), and Complex IV (FCC=1.02) in hESCs. In 2102Ep cells.Complex II 
(FCC=0.75) and Complex IV (FCC=1.24) are the main regulators, since FCC values for other 
complexes were considerably lower (Table 2). It was impossible to determine FCC for 
Complex III in hESCs, because of the high sensitivity of these cells to Complex III inhibition. 
Beyond 0.15 nM of antimycin A, the inhibition was suddenly increased and the rate of 
respiration dropped sharply. 
Our results indicated a notable difference in the control exerted by the phosphorylating system 
of OXPHOS constituted by the ATP synthase, ANT and Pi carrier in 2102Ep and hESCs. The 
FCCfor ANT in 2102Ep cells exceeded 8 times the value obtained for hESCs (FCC=0.62 
versus FCC=0.07). On the contrary, the FCC for Pi carrier was significantly lower in 2102Ep 
cells (FCC=0.03 versus FCC=0.26).The FCC value estimated for ATP synthase was 3 times 
higher in 2102Ep cells (FCC=0.63) compared to hESCs (FCC=0.22). 
The total FCCs values for both cell types exceeded significantly the theoretic value for linear 
systems, which is considered to be close to 1[42]. 2102Ep cells had higher total FCC values 
(FCC=3.98) than hESCs (FCC>2.7). Altogether, these results demonstrate that the role of 
respiratory chain complexes and ATP synthase in energy metabolism of 2102Ep cells differ 
considerably from that in normal stem cells. 
4 Discussion	
Cancer stem cells may acquire numerous properties of normal stem cells including their 
ability to self-renew, relative quiescence, expression of the same surface markers and 
activation of the same cell signaling pathways [43]. The specific depletion of CSC that 
represents a promising approach in clinical cancer therapy is challenging due to this 
similarity. Therefore, it is necessary to discover cellular or metabolic features that could help 
to distinguish CSCs from normal stem cells. In order to elucidate the possible differences, we 
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have chosen normal hESC (H9) to compare with embryonal carcinoma cells (2102Ep) that 
express similar pluripotency-associated marker proteins but have limited differentiation 
ability[44]. 
In normal cells, the oxidative phosphorylation is closely linked to phosphotransfer 
systemswhere adenylate kinase and creatine kinase networks transport ATP from 
mitochondria to ATP-consumption sites[16]. We have demonstrated that the expression and 
the activity of several major components of the phosphotransfer system vary notably between 
2102Ep cells and hESCs. In the current study, the deficiency of CK network was 
accompanied by the up-regulation of AK network in 2102Ep cells. The significant decrease of 
CK levels has been previously reported upon the transformation of skeletal muscle into 
sarcoma [45]. Several reports have indicated reduced levels of CK in brain cancer, colon 
cancer, prostate cancer and other malignancies [20, 46].The current findings about the 
expression and activity of different AK isoforms during cancerogenesis are contradictory. 
Although the increased expression of AK2 has been found in breast CSC[47] and prostate 
cancer cells[48], another study states that AK2 is rather a negative regulator of tumor 
growth[49].On the other hand, it has been reported that the up-regulation of AK2 provides the 
energy required for the proliferation of hematopoietic stem cells [50] and plays an important 
role in communication between mitochondria and nucleus [16]. AK2 deficiency impairs 
embryonic development and causes hematopoietic defects indicating the significance of AK2 
in the energy metabolism of normal stem cells [50-51].Further studies are needed to find out 
how AK2 expression and its compartmentalization influence cellular proliferation. A brief 
analysis of data from The Cancer Genome Atlas (TCGA) using the cBioPortal shows genomic 
alterations (amplification, deletion, or base pair mutation) in phosphotransfer systems in many 
cancers (Fig. 1S). The most frequent alteration was detected in breast cancer xenografts where 
48% of tumors exhibited amplified number of AK2 and HK2suggesting that tumor cells with 
elevated levels of AK2 and HK2 may be one of the key players in cancer development and 
progression. A closer look at specific AK2 and HK2 alterations across various tumors reveals 
that amplification is the most common genomic alteration of AK2 while HK2 might be either 
amplified or mutated (Table 1S). 
In agreement with previous reports, our results demonstrated that both normal and cancer 
stem cells have functional mitochondria. Although CSCs are often considered to be a 
glycolytic cell type, many recent reports identify oxidative metabolism as the preferred energy 
production mechanism in various CSCs [17, 52].Moreover, it has been shown that functional 
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mitochondria are crucial for the maintenance of CSC phenotype [17, 47]. Enhanced 
mitochondrialfunction of CSCs has been associated with tumor growth [53], increased 
metastatic potential[54] and resistance to chemotherapy[55]. 
Our results showed that 2102Ep cells consume lower levels of oxygen than normal stem cells. 
The reduced respiration rate may indicate that the mitochondrial respiratory chain does not 
operate sufficiently to generate an effective proton gradient. However, our results 
demonstrated that reduced mitochondrial respiration in 2102Ep cells was not the result of the 
impairment of respiratory chain complexes because all mitochondrial respiratory complexes 
were functionally active and their activities were equivalent in both cell lines. No differences 
were found between the rates of proton leak in studied cell lines. Mitochondria are 
functioning in the vast majority of cells at a basal energy level that is required for cell survival 
and normal performance. The term “reserve respiratory capacity” is used to characterize the 
additional capacity available in cells to produce energy in response to certain conditions or 
increased stress[56]. One possible reason for the elevated reserve respiratory capacity in 
2102Ep cells could be the increase of substrate entry into the TCA cycle [57]. In support of 
this hypothesis, it has been shown that TCA cycle intermediates are enriched in another 
(NTERA2) human embryonal carcinoma cell line [58]. 
We applied MCA to identify target reactions that control respiratory chain activity in 2102Ep 
cells and hESCs. Our results from MCA provided indirect evidence to conclude that the 
complexes II and IV share larger control strength over respiration in 2102Ep than in hESCs. 
Complex I exerted larger control over respiration in hESCs. Interestingly, Complex I has been 
shown to play an important role in cellular differentiation by generating reactive oxygen 
species (ROS) that stimulate muscle cell differentiation[59]. Taking into account that 2102Ep 
cells exhibit reduced ability to differentiate; Complex I in these cells may have distinct 
functional features compared to hESCs. 
Completely different control patterns were also obtained for ATP synthase and its associated 
substrate suppliers, Pi carrier, and ANT. It has long been known that the coupling of ATP 
synthesis to oxygen consumption is not perfect due to the proton leak across the inner 
membrane of mitochondria[60]. Two groups of mitochondrial proteins contribute 
significantly to proton leak, uncoupling proteins and the adenine nucleotide translocator[61]. 
In current work the FCC for ANT was considerably higher in 2102Ep cells, showing that 
ANT exerts a higher degree of control over respiration and may play an important role in the 
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regulation of proton leak in these cells. This is supported by the recent finding that the 
regulation of mithochondrial proton leak depends on the metabolic conditions.[62]. Thus, it 
can be assumed that the regulation of proton leak could be also distinctly mediated in cells 
with different cellular metabolic states. However, additional research is needed to control this 
hypothesis. 
The total FCCs were higher than expected for both hESCs and 2102Epcells, contradicting the 
summation theorem of MCA according to which the sum of the FCCs of the enzymes of a 
metabolic pathway should be equal to 1. High total FCCs in both cell lines might be the result 
of branched pathways or direct substrate channeling between the protein (super)complexes 
[42].Very little is known about the organization of respiratory chain in stem cells. It has been 
shown that the differentiation of human mesenchymal stem cells (hMSCs) is accompanied by 
the increased mitochondrial biogenesis and formation of supercomplexes[8, 63]. Hoffmann et 
al. has confirmed the presence of several supercomplexes in hMSCs, although the number of 
supramolecular assemblies was significantly reduced compared with differentiated cells[8].It 
has been shown that in mitochondria with impaired respiration, ATP synthase and ANT may 
operate in the opposite direction compared with normal cells generating high ATP level and 
reverse proton gradient[64]. Definitely, the role of mitochondrial biogenesis and OXPHOS 
organization in the regulation of cellular differentiation and cancer development represents an 
important direction for future research. 
Rapidly proliferating hESCs and CSCs are forced to adapt their cellular metabolism to meet 
their demand for energy and increased biosynthesis of macromolecules[65].The Warburg 
effect represents one of the most common adaptive mechanisms which is acquired by highly 
proliferative and malignant cells to support their metabolic needs [66]. While the majority of 
normal differentiated cells use glycolysis followed by aerobic oxidation of pyruvate in the 
mitochondria to eventually produce ATP, highly proliferating cells prefer glycolysis followed 
by lactic acid fermentation during the process called “aerobic glycolysis” or “Warburg 
effect”[66]. Although aerobic glycolysis provides less ATP per molecule of glucose, it 
produces energy much faster and provides many intermediates for the production of proteins, 
lipids, and nucleotides[67].In order to compare the level of aerobic glycolysis in our 
experimental models (Warburg-Pedersen) we evaluated the effect of exogenously added 
glucose on the cellular respiration. Our results showed up-regulation of aerobic glycolysis in 
2102Ep compared to hESCs. 
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Altogether, our results confirm that the embryonal carcinoma2102Epcells display distinct 
bioenergetic profile compared to normal hESCs. The shift in energy distribution towards AK 
network, alterations in the regulation of respiratory chain as well as suppressed respiration 
may serve as indicators of tumorigenic stem cell. In addition, as differences in bioenergetic 
profile indicate different regulation of various cellular processes, this data should be taken 
into account for future use of these cell lines as in vitro stem cell or cancer stem cell 
models.Clearly, further extensive characterization of bioenergetics of normal and cancer cells 
is necessary in order to extend our knowledge of the mechanisms behind the cellular 
proliferation and differentiation. Ultimately, this will help to develop an effective treatment 
that would selectively target CSCs sparing normal stem cells and, thus, reducing side effects 
of conventional anti-cancer therapy. 
5 Conclusions	
Current study shed light on several aspects of energy metabolism in normal and tumorigenic 
stem cells. Our results showed that the bioenergetic profile of 2102Ep cells clearly 
distinguishes them from normal hESCs. Reduced oxygen consumption, increased aerobic 
glycolysis and shifted energy metabolism towards AK network represented the bioenergetic 
signature of this carcinoma cell line. Present and future studies will potentially aid in the 
understanding of metabolic properties of stem cells and establishment of effective strategies 
for identifying cells with increased tumorigenic potential. 
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FIGURE LEGENDS 
Fig.1. Comparison of the mRNA expression levels of key enzymes involved in cellular 
energy homeostasis  in hESCs and 2102Ep cells. Expression of the indicated mRNA was 
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quantified using qPCR. Data were normalized to β-actin mRNA and expressed as a fold 
change relative to hESCs. The results are means ± SEM of three individual studies. *p<0.05 
and **p<0.005 
Fig.2. Respiratory properties of hESC and 2102Ep cells.(A) Mitochondrial membranes 
integrity validation test. Adenosine diphosphate, ADP; Cytochrome c, Cyt c; 
Carboxyatractyloside, CAT. (B) State 2 and state 3 respiration rates. All rates were 
normalized to total protein concentration in the same samples. (C) Respiratory control indexes 
(RCIs). RCIs were calculated as the ratios between state 2 and state 3 rates. All data are mean 
± SEM of 5–6 independent experiments. *p<0.05. 
Fig.3. Assessment of mitochondrial function in hESCs and 2102Ep cells.(A) Representative 
respirometric trace with schematic representation of the mitochondrial function assay. Arrows 
indicate the titrations into the oxygraph chamber. Maximal respiratory rate was determined 
with FCCP titration. Maximal uncoupled respiration was reached at 0.5µM FCCP followed by 
inhibition of electron transfer (ETS) by antimycin A to measure residual oxygen consumption 
(ROX). (B) Quantitative analysis of mitochondrial OCR readings. (C) Functional properties 
of mitochondrial respiration. Proton leak was calculated as (VLEAK-VROX)/VROUTINE; ATP-
linked respiration: (VROUTINE-VLEAK)/VROUTINE; maximal respiration: (VFCCP-VROX)/VROUTINE; 
respiratory reserve capacity: (VFCCP-VROUTINE)/VROUTINE. 
Fig.4.Effect of exogenously added glucose on the rate of oxygen consumption. The effect of 
glucose was estimated as a degree of glucose-mediated respiration compared to State 3 
respiration and expressed as the glucose index (Iglu): Iglu(%)=(Vglu-VATP)/(VADP-VATP).Results 
represent means ± SEM, n=5. The difference in the mean values of the two groups is 
statistically significant, * p<0.05. Cytochrome c, Cyt c. 
Fig.5.Functional activity of respiratory chain complexes. The Complex IV-dependent 
respiration was calculated as VTMPD/Asc–VTMPD/Asc+NaCN where VTMPD/Asc and VTMPD+NaCNare 
TMPD-stimulated respiration rates before and after addition of NaCN. Results represent 
means ± SEM, n=5.Asc – ascorbate, TMPD - N,N,N′,N′-tetramethyl-p-phenylenediamine, CI, 
CII, CIII and CIV – Complexes I, II, III and IV respectively. Bars are SEM. 
Fig.6. Immunocytochemical analysis of Oct-4 (green) and MitoTracker Red (red) in hESC 
and 2102Ep cells. Nuclei are stained with DAPI (blue). Scale bars, 10 µm. 
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TABLES 
Table 1. The activity of HK, CK and CS in hESCs and 2102Ep cells 
 Enzyme activities, mU/mg protein  
 hESC 
mean±SEM 
2102Ep 
mean±SEM 
p-values 
Hexokinase 67.28±2.75 71.46±7.91 0.64 
Creatine kinase 159.84±3.70 12.75±2.15 <0.0001 
Citrate synthase 52.26±3.07 64.77±4.26 0.08 
Total adenylate kinase 
(AK) 64.39±2.55 179.85±5.73 <0.001 
AK1 28.77±1.6 (46%*) 37.44±3.86 (21%) 0.1 
AK2 33.10±1.00 (54%) 142.42±3.29 (79%) <0.001 
Notes: *% from the total AK activity. 
 
Table 2. Flux control coefficients (FCC) of respiratory chain complexes for hESCs and 
2102Ep cells 
ETC component Inhibitor 
hESCs, 
FCC 
2102Ep, 
FCC 
Complex I Rotenone 0.76 0.40 
Complex II Atpenin A5 0.37 0.75 
Complex III Antimycin A NA 0.31 
Complex IV Na cyanide 1.02 1.24 
ATP synthase Oligomycin 0.22 0.63 
ANT Carboxyatractyloside 0.07 0.62 
Pi carrier Mersalyl 0.26 0.03 
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